GPR32 and acute lymphoblastic leukemia: On the other hand, GPR32 has a putative agonist called resolvin D1 (RvD1) with highaffinity binding, which has been connected to regulate leukocyte responses, includingenhancing macrophage phagocytosis.87 RvD1 further has been correlatedwith anti-inflammatory responses as well as decreasing cancer growth by stimulatingmonocytes.88 In this case, the downregulation of GPR32 couldpotentially have some crucial roles in ALL.